News and Analysis

Everest Medicines lands $310m Series C

Everest Medicines, a biopharmaceutical company, has raised $310 million in Series C financing.

-

Everest Medicines, a biopharmaceutical company, has raised $310 million in Series C financing. Everest’s backers include Janchor Partners, RA Capital Management and Hillhouse Capital.
Source: Press Release